–
BridgeBio Oncology Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
millions USD
FY23:
FY24:
–
FY25:
–
(positive)
Change from FY23 to FY25
millions USD
FY23:
−0.04
FY24:
−80.9
FY25:
−146
(positive)
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
−80.7
FY25:
−145
(positive)
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
−74.3
FY25:
−134
(positive)
Change from FY23 to FY25
millions USD
FY23:
−0.04
FY24:
−74.3
FY25:
−134
All amounts in millions USD